{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T08:55:30Z","timestamp":1785228930983,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071974"],"award-info":[{"award-number":["82071974"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202225"],"award-info":[{"award-number":["82202225"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371998"],"award-info":[{"award-number":["82371998"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Guangdong Science and Technology Planning Project, China","award":["2022A0505050042"],"award-info":[{"award-number":["2022A0505050042"]}]},{"name":"Guangzhou Science and Technology Program","award":["202206010106"],"award-info":[{"award-number":["202206010106"]}]},{"name":"Guangzhou Science and Technology Program","award":["2023A03J0610"],"award-info":[{"award-number":["2023A03J0610"]}]},{"name":"Guangzhou Science and Technology Program","award":["2023A04J1921"],"award-info":[{"award-number":["2023A04J1921"]}]},{"name":"the Clinical Frontier Technology Program of the First Affiliated Hospital of Jinan University","award":["JNU1AF-CFTP-2022-a01214"],"award-info":[{"award-number":["JNU1AF-CFTP-2022-a01214"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s00259-024-06964-8","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T02:03:02Z","timestamp":1730426582000},"page":"864-875","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Synthesis, preclinical assessment, and first-in-human study of [18F]d4-FET for brain tumor imaging"],"prefix":"10.1007","volume":"52","author":[{"given":"Lu","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanfan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianghe","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijian","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guocong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjie","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven H.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8049-1991","authenticated-orcid":false,"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"6964_CR1","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","volume":"19","author":"QT Ostrom","year":"2017","unstructured":"Ostrom QT, Gittleman H, Liao P, Vecchione-Koval T, Wolinsky Y, Kruchko C, et al. CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010\u20132014. Neuro Oncol. 2017;19:v1\u201388.","journal-title":"Neuro Oncol"},{"key":"6964_CR2","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10143-020-01337-9","volume":"44","author":"N Verburg","year":"2021","unstructured":"Verburg N, de Witt Hamer PC. State-of-the-art imaging for glioma surgery. Neurosurgical Rev. 2021;44:1331\u201343.","journal-title":"Neurosurgical Rev"},{"key":"6964_CR3","doi-asserted-by":"crossref","first-page":"n1560","DOI":"10.1136\/bmj.n1560","volume":"374","author":"C McKinnon","year":"2021","unstructured":"McKinnon C, Nandhabalan M, Murray SA, Plaha P. Glioblastoma: clinical presentation, diagnosis, and management. BMJ. 2021;374:n1560.","journal-title":"BMJ"},{"key":"6964_CR4","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1038\/s41467-023-39731-8","volume":"14","author":"M Harat","year":"2023","unstructured":"Harat M, Rakowska J, Harat M, Szylberg T, Furtak J, Miechowicz I, et al. Combining amino acid PET and MRI imaging increases accuracy to define malignant areas in adult glioma. Nat Commun. 2023;14:4572.","journal-title":"Nat Commun"},{"key":"6964_CR5","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s00259-022-05760-6","volume":"49","author":"R Laudicella","year":"2022","unstructured":"Laudicella R, Quartuccio N, Argiroffi G, Alongi P, Baratto L, Califaretti E, et al. Correction to: Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas. Eur J Nucl Med Mol Imaging. 2022;49:2104.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6964_CR6","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s13139-024-00847-4","volume":"58","author":"D Kim","year":"2024","unstructured":"Kim D, Lee SH, Hwang HS, Kim SJ, Yun M. Recent Update on PET\/CT Radiotracers for Imaging Cerebral Glioma. Nucl Med Mol Imaging. 2024;58:237\u201345.","journal-title":"Nucl Med Mol Imaging"},{"key":"6964_CR7","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/neuonc\/now058","volume":"18","author":"NL Albert","year":"2016","unstructured":"Albert NL, Weller M, Suchorska B, Galldiks N, Soffietti R, Kim MM, et al. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas. Neuro Oncol. 2016;18:1199\u2013208.","journal-title":"Neuro Oncol"},{"key":"6964_CR8","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1007\/s00259-022-05817-6","volume":"49","author":"A Piccardo","year":"2022","unstructured":"Piccardo A, Albert NL, Borgwardt L, Fahey FH, Hargrave D, Galldiks N, et al. Joint EANM\/SIOPE\/RAPNO practice guidelines\/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [18F]FDG: version 1.0. Eur J Nucl Med Mol Imaging. 2022;49:3852\u201369.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6964_CR9","first-page":"4690","volume":"26","author":"H Feng","year":"2020","unstructured":"Feng H, Zhang H, Wang M, Vannam R, Wang H, Yan X, et al. Improving Tumor-to-Background Contrast through Hydrophilic Tetrazines: The Construction of 18F-Labeled PET Agents Targeting Nonsmall Cell Lung Carcinoma. Chemistry (Weinheim an der Bergstrasse, Germany). 2020;26:4690\u20134.","journal-title":"Chemistry (Weinheim an der Bergstrasse, Germany)"},{"key":"6964_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13550-023-00981-8","volume":"13","author":"AH Dias","year":"2023","unstructured":"Dias AH, Jochumsen MR, Zacho HD, Munk OL, Gormsen LC. Multiparametric dynamic whole-body PSMA PET\/CT using [68Ga]Ga-PSMA-11 and [18F]PSMA-1007. EJNMMI Res. 2023;13:31.","journal-title":"EJNMMI Res"},{"key":"6964_CR11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1060028018797110","volume":"53","author":"EM Russak","year":"2019","unstructured":"Russak EM, Bednarczyk EM. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53:211\u20136.","journal-title":"Ann Pharmacother"},{"key":"6964_CR12","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41573-023-00703-8","volume":"22","author":"RMC Di Martino","year":"2023","unstructured":"Di Martino RMC, Maxwell BD, Pirali T. Deuterium in drug discovery: progress, opportunities and challenges. Nat Rev Drug Discov. 2023;22:562\u201384.","journal-title":"Nat Rev Drug Discov"},{"key":"6964_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01375-9","author":"K Liao","year":"2024","unstructured":"Liao K, Chen JH, Ma J, Dong CC, Bi CY, Gao YB, et al. Preclinical characterization of [18F]D2-LW223: an improved metabolically stable PET tracer for imaging the translocator protein 18 kDa (TSPO) in neuroinflammatory rodent models and non-human primates. Acta Pharmacol Sin. 2024. https:\/\/doi.org\/10.1038\/s41401-024-01375-9.","journal-title":"Acta Pharmacol Sin"},{"key":"6964_CR14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nbt0617-493","volume":"35","author":"C Schmidt","year":"2017","unstructured":"Schmidt C. First deuterated drug approved. Nat Biotechnol. 2017;35:493\u20134.","journal-title":"Nat Biotechnol"},{"key":"6964_CR15","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1038\/s41401-022-00895-6","volume":"43","author":"HJ Qian","year":"2022","unstructured":"Qian HJ, Wang Y, Zhang MQ, Xie YC, Wu QQ, Liang LY, et al. Safety, tolerability, and pharmacokinetics of VV116, an oral nucleoside analog against SARS-CoV-2, in Chinese healthy subjects. Acta Pharmacol Sin. 2022;43:3130\u20138.","journal-title":"Acta Pharmacol Sin"},{"key":"6964_CR16","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/acs.jmedchem.8b01366","volume":"62","author":"W Mori","year":"2019","unstructured":"Mori W, Yamasaki T, Fujinaga M, Ogawa M, Zhang Y, Hatori A, et al. Development of 2-(2-(3-(4-([18F]Fluoromethoxy- d2)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione for Positron-Emission-Tomography Imaging of Phosphodiesterase 10A in the Brain. J Med Chem. 2019;62:688\u201398.","journal-title":"J Med Chem"},{"key":"6964_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.nucmedbio.2020.03.003","volume":"92","author":"Z Zha","year":"2021","unstructured":"Zha Z, Ploessl K, Choi SR, Alexoff D, Kung HF. Preclinical evaluation of [18F]D3FSP, deuterated AV-45, for imaging of \u03b2-amyloid in the brain. Nucl Med Biol. 2021;92:97\u2013106.","journal-title":"Nucl Med Biol"},{"key":"6964_CR18","doi-asserted-by":"crossref","first-page":"116163","DOI":"10.1016\/j.neuroimage.2019.116163","volume":"203","author":"B Nie","year":"2019","unstructured":"Nie B, Wang L, Hu Y, Liang S, Tan Z, Chai P, et al. A population stereotaxic positron emission tomography brain template for the macaque and its application to ischemic model. Neuroimage. 2019;203:116163.","journal-title":"Neuroimage"},{"key":"6964_CR19","doi-asserted-by":"crossref","first-page":"7924","DOI":"10.21037\/qims-23-118","volume":"13","author":"L Hou","year":"2023","unstructured":"Hou L, Zhang H, Li Y, Zhu H, Liao K, Guo B, et al. Correlation analysis of positron emission tomography\/computed tomography-magnetic resonance imaging of cannabinoid type 1 receptor in the lumbar spine and brain of aged osteoporosis female cynomolgus monkeys. Quant Imaging Med Surg. 2023;13:7924\u201335.","journal-title":"Quant Imaging Med Surg"},{"key":"6964_CR20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/RLU.0000000000002890","volume":"45","author":"D Akhoundova","year":"2020","unstructured":"Akhoundova D, Hiltbrunner S, Mader C, F\u00f6rster R, Kraft J, Schwanh\u00e4usser B, et al. 18F-FET PET for Diagnosis of Pseudoprogression of Brain Metastases in Patients With Non-Small Cell Lung Cancer. Clin Nucl Med. 2020;45:113\u20137.","journal-title":"Clin Nucl Med"},{"key":"6964_CR21","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1007\/s00259-019-04656-2","volume":"47","author":"S Song","year":"2020","unstructured":"Song S, Cheng Y, Ma J, Wang L, Dong C, Wei Y, et al. Simultaneous FET-PET and contrast-enhanced MRI based on hybrid PET\/MR improves delineation of tumor spatial biodistribution in gliomas: a biopsy validation study. Eur J Nucl Med Mol Imaging. 2020;47:1458\u201367.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6964_CR22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00259-009-1219-5","volume":"37","author":"N Galldiks","year":"2010","unstructured":"Galldiks N, Ullrich R, Schroeter M, Fink GR, Jacobs AH, Kracht LW. Volumetry of [11C]-methionine PET uptake and MRI contrast enhancement in patients with recurrent glioblastoma multiforme. Eur J Nucl Med Mol Imaging. 2010;37:84\u201392.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6964_CR23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.21037\/qims-20-723","volume":"11","author":"T Hua","year":"2021","unstructured":"Hua T, Zhou W, Zhou Z, Guan Y, Li M. Heterogeneous parameters based on 18F-FET PET imaging can non-invasively predict tumor grade and isocitrate dehydrogenase gene 1 mutation in untreated gliomas. Quant Imaging Med Surg. 2021;11:317\u201327.","journal-title":"Quant Imaging Med Surg"},{"key":"6964_CR24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awh399","volume":"128","author":"D Pauleit","year":"2005","unstructured":"Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, M\u00fcller HW, et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain. 2005;128:678\u201387.","journal-title":"Brain"},{"key":"6964_CR25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13550-017-0295-y","volume":"7","author":"M Unterrainer","year":"2017","unstructured":"Unterrainer M, Vettermann F, Brendel M, Holzgreve A, Lifschitz M, Z\u00e4hringer M, et al. Towards standardization of 18F-FET PET imaging: do we need a consistent method of background activity assessment? EJNMMI Res. 2017;7:48.","journal-title":"EJNMMI Res"},{"key":"6964_CR26","first-page":"205","volume":"40","author":"HJ Wester","year":"1999","unstructured":"Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, et al. Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med. 1999;40:205\u201312.","journal-title":"J Nucl Med"},{"key":"6964_CR27","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00259-003-1118-0","volume":"30","author":"D Pauleit","year":"2003","unstructured":"Pauleit D, Floeth F, Herzog H, Hamacher K, Tellmann L, M\u00fcller HW, et al. Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine. Eur J Nucl Med Mol Imaging. 2003;30:519\u201324.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6964_CR28","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s12149-021-01656-x","volume":"35","author":"H Sagara","year":"2021","unstructured":"Sagara H, Inoue K, Yaku H, Ohsawa A, Someya T, Yanagisawa K, et al. Optimization of injection dose in 18F-FDG PET\/CT based on the 2020 national diagnostic reference levels for nuclear medicine in Japan. Ann Nucl Med. 2021;35:1177\u201386.","journal-title":"Ann Nucl Med"},{"key":"6964_CR29","first-page":"11751","volume":"27","author":"J Steverlynck","year":"2021","unstructured":"Steverlynck J, Sitdikov R, Rueping M. The Deuterated \u201cMagic Methyl\u201d Group: A Guide to Site-Selective Trideuteromethyl Incorporation and Labeling by Using CD(3) Reagents. Chemistry (Weinheim an der Bergstrasse, Germany). 2021;27:11751\u201372.","journal-title":"Chemistry (Weinheim an der Bergstrasse, Germany)"},{"key":"6964_CR30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0005-2736(01)00384-4","volume":"1514","author":"O Yanagida","year":"2001","unstructured":"Yanagida O, Kanai Y, Chairoungdua A, Kim DK, Segawa H, Nii T, et al. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines. Biochim Biophys Acta. 2001;1514:291\u2013302.","journal-title":"Biochim Biophys Acta"},{"key":"6964_CR31","doi-asserted-by":"crossref","first-page":"107964","DOI":"10.1016\/j.pharmthera.2021.107964","volume":"230","author":"Y Kanai","year":"2022","unstructured":"Kanai Y. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacol Ther. 2022;230:107964.","journal-title":"Pharmacol Ther"},{"key":"6964_CR32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/pin.12323","volume":"65","author":"H Koshi","year":"2015","unstructured":"Koshi H, Sano T, Handa T, Yanagawa T, Saitou K, Nagamori S, et al. L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors. Pathol Int. 2015;65:460\u20137.","journal-title":"Pathol Int"},{"key":"6964_CR33","first-page":"4819","volume":"30","author":"H Imai","year":"2010","unstructured":"Imai H, Kaira K, Oriuchi N, Shimizu K, Tominaga H, Yanagitani N, et al. Inhibition of L-type amino acid transporter 1 has antitumor activity in non-small cell lung cancer. Anticancer Res. 2010;30:4819\u201328.","journal-title":"Anticancer Res"},{"key":"6964_CR34","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/j.1349-7006.2008.00969.x","volume":"99","author":"K Kaira","year":"2008","unstructured":"Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N, et al. l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci. 2008;99:2380\u20136.","journal-title":"Cancer Sci"},{"key":"6964_CR35","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/bjc.2012.310","volume":"107","author":"K Kaira","year":"2012","unstructured":"Kaira K, Sunose Y, Arakawa K, Ogawa T, Sunaga N, Shimizu K, et al. Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer. Br J cancer. 2012;107:632\u20138.","journal-title":"Br J cancer"},{"key":"6964_CR36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1472-6890-12-4","volume":"12","author":"Z Haining","year":"2012","unstructured":"Haining Z, Kawai N, Miyake K, Okada M, Okubo S, Zhang X, et al. Relation of LAT1\/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas. BMC Clin Pathol. 2012;12:4.","journal-title":"BMC Clin Pathol"},{"key":"6964_CR37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1227\/01.neu.0000316018.51292.19","volume":"62","author":"K Kobayashi","year":"2008","unstructured":"Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, Shiokawa Y, et al. Enhanced tumor growth elicited by L-type amino acid transporter 1 in human malignant glioma cells. Neurosurgery. 2008;62:493\u2013503.","journal-title":"Neurosurgery"},{"key":"6964_CR38","doi-asserted-by":"crossref","first-page":"115103","DOI":"10.1016\/j.bcp.2022.115103","volume":"201","author":"N Cappoli","year":"2022","unstructured":"Cappoli N, Jenkinson MD, Russo CD, Dickens D. LAT1, a novel pharmacological target for the treatment of glioblastoma. Biochem Pharmacol. 2022;201:115103.","journal-title":"Biochem Pharmacol"},{"key":"6964_CR39","first-page":"217","volume":"29","author":"N Nakada","year":"2014","unstructured":"Nakada N, Mikami T, Hana K, Ichinoe M, Yanagisawa N, Yoshida T, et al. Unique and selective expression of L-amino acid transporter 1 in human tissue as well as being an aspect of oncofetal protein. Histol Histopathol. 2014;29:217\u201327.","journal-title":"Histol Histopathol"},{"key":"6964_CR40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neures.2004.08.003","volume":"50","author":"DK Kim","year":"2004","unstructured":"Kim DK, Kim IJ, Hwang S, Kook JH, Lee M-C, Shin BA, et al. System L-amino acid transporters are differently expressed in rat astrocyte and C6 glioma cells. Neurosci Res. 2004;50:437\u201346.","journal-title":"Neurosci Res"},{"key":"6964_CR41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13244-020-00926-y","volume":"11","author":"J Zhao","year":"2020","unstructured":"Zhao J, Hamm B, Brenner W, Makowski MR. Lesion-to-background ratio threshold value of SUVmax of simultaneous [68Ga] Ga-PSMA-11 PET\/MRI imaging in patients with prostate cancer. Insights Imaging. 2020;11:1\u201311.","journal-title":"Insights Imaging"},{"key":"6964_CR42","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaoncol.2019.6143","volume":"6","author":"AM Molinaro","year":"2020","unstructured":"Molinaro AM, Hervey-Jumper S, Morshed RA, Young J, Han SJ, Chunduru P, et al. Association of Maximal Extent of Resection of Contrast-Enhanced and Non-Contrast-Enhanced Tumor With Survival Within Molecular Subgroups of Patients With Newly Diagnosed Glioblastoma. JAMA Oncol. 2020;6:495\u2013503.","journal-title":"JAMA Oncol"},{"key":"6964_CR43","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","volume":"95","author":"M Lacroix","year":"2001","unstructured":"Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95:190\u20138.","journal-title":"J Neurosurg"},{"key":"6964_CR44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/2011.2.JNS10998","volume":"115","author":"N Sanai","year":"2011","unstructured":"Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS. An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg. 2011;115:3\u20138.","journal-title":"J Neurosurg"},{"key":"6964_CR45","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/neuonc\/nos128","volume":"14","author":"RF Barajas Jr","year":"2012","unstructured":"Barajas RF Jr, Phillips JJ, Parvataneni R, Molinaro A, Essock-Burns E, Bourne G, et al. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. Neuro Oncol. 2012;14:942\u201354.","journal-title":"Neuro Oncol"},{"key":"6964_CR46","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.3390\/ijms150711832","volume":"15","author":"K Parvez","year":"2014","unstructured":"Parvez K, Parvez A, Zadeh G. The diagnosis and treatment of pseudoprogression, radiation necrosis and brain tumor recurrence. Int J Mol Sci. 2014;15:11832\u201346.","journal-title":"Int J Mol Sci"},{"key":"6964_CR47","doi-asserted-by":"crossref","unstructured":"Hygino da Cruz LC, Jr., Rodriguez I, Domingues RC, Gasparetto EL, Sorensen AG. Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR. 2011;32:1978\u201385.","DOI":"10.3174\/ajnr.A2397"},{"key":"6964_CR48","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/neuonc\/noy098","volume":"21","author":"M Kunz","year":"2019","unstructured":"Kunz M, Albert NL, Unterrainer M, la Fougere C, Egensperger R, Sch\u00fcller U, et al. Dynamic 18F-FET PET is a powerful imaging biomarker in gadolinium-negative gliomas. Neuro Oncol. 2019;21:274\u201384.","journal-title":"Neuro Oncol"},{"key":"6964_CR49","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.2174\/0929867325666171123202644","volume":"25","author":"B Muoio","year":"2018","unstructured":"Muoio B, Giovanella L, Treglia G. Recent Developments of 18F-FET PET in Neuro-oncology. Curr Med Chem. 2018;25:3061\u201373.","journal-title":"Curr Med Chem"},{"key":"6964_CR50","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00259-019-04384-7","volume":"46","author":"JM Werner","year":"2019","unstructured":"Werner JM, Stoffels G, Lichtenstein T, Borggrefe J, Lohmann P, Ceccon G, et al. Differentiation of treatment-related changes from tumour progression: a direct comparison between dynamic FET PET and ADC values obtained from DWI MRI. Eur J Nucl Med Mol Imaging. 2019;46:1889\u2013901.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-024-06964-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-024-06964-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T04:28:50Z","timestamp":1737520130000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-024-06964-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["6964"],"URL":"https:\/\/doi.org\/10.1007\/s00259-024-06964-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiment protocol listed in the manuscript has been reviewed and approved by Laboratory Animal Welfare and Ethics Committee of Jinan University. (approval number: IACUC-20220923\u201303, IACUC-20230506\u201308, IACUC-20230508\u201312, IACUC-20231020\u201301). The clinical validation study was approved by the Ethics Committee of the First Affiliated Hospital of Jinan University (7 Jul 2023 \/ KY-2023\u2013189), and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that human research participants provided informed consent for publication of the images in Figs.\u00a0a,  and .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}